Showing results (351-360 of 4,380) with videos related to

Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|July 24, 2018
Discovery of Natural Product Derived Labdane Appended Triazoles as Potent Pancreatic Lipase InhibitorsRenjitha Jalaja, Shyni G Leela, Praveen K Valmiki, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
PK/PD Disconnect Observed with a Reversible Endothelial Lipase InhibitorJon J Hangeland, Lynn M Abell, Leonard P Adam, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Inhibition of Connexin Hemichannels by New Amphiphilic Aminoglycosides without Antibiotic ActivityMadher N AlFindee, Yagya P Subedi, Mariana C Fiori, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Identification of N-Benzyl 3,5-Dinitrobenzamides Derived from PBTZ169 as Antitubercular AgentsLinhu Li, Kai Lv, Yupeng Yang, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Dipeptide Prodrugs of the Glutamate Modulator RiluzoleJeffrey C Pelletier, Suzie Chen, Haiyan Bian, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Profiling and Application of Photoredox C(sp3)-C(sp2) Cross-Coupling in Medicinal ChemistryRui Zhang, Guoqing Li, Michael Wismer, et al.
ACS Medicinal Chemistry Letters|June 26, 2018
Why Decreasing Lipophilicity Alone Is Often Not a Reliable Strategy for Extending IV Half-lifeFabio Broccatelli, Ignacio Aliagas, Hao Zheng
ACS Medicinal Chemistry Letters|June 26, 2018
Strategy for Extending Half-life in Drug Design and Its SignificanceHakan Gunaydin, Michael D Altman, J Michael Ellis, et al.
ACS Medicinal Chemistry Letters|June 26, 2018
Development of Highly Potent and Selective Steroidal Inhibitors and Degraders of CDK8John M Hatcher, Eric S Wang, Liv Johannessen, et al.
ACS Medicinal Chemistry Letters|September 24, 2016
Identification and Structural Characterization of Three New Metabolites of Bupropion in HumansJennifer E Sager, John R Choiniere, Justine Chang, et al.
Pageof 438